GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Polomar Health Services PMHS · USD

N/A · US listing · 🇺🇸 United States

Compare

0.19

—

Close of 3 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$648,231

FY2018FY2025

Net income

−$10.7m

FY2018FY2025

Free cash flow

−$396,000

FY2018FY2025

Shareholders' equity

−$1.2m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2019FY2018
Revenue$648,231$58,824$41,844$34,526———
Gross profit$460,099$30,903$37,550$34,526———
Operating income−$10.6m−$1.3m−$416,500−$181,450−$35,650−$1,790−$91,130
Net income−$10.7m−$1.3m−$416,500−$181,124−$168,396$99,069−$93,251
Diluted earnings per share-0.38-0.05-0.04-0.00-0.540.32-0.30

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2019FY2018
Total assets$390,043$10.0m$244$261,484——$46,797
Cash and short-term investments$132,150$6,191$244$225,619——$1,789
Total liabilities$1.6m$14,864$13,783$74,715$35,646—$95,386
Debt$14,864$49,181$81,664$69,703$32,694—$89,109
Shareholders' equity−$1.2m$9.9m−$13,539$186,769−$35,646$627,153−$48,589
Shares outstanding28m28m11m108m0m0m0m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2019FY2018
Cash from operations−$395,995−$1.0m−$371,864−$40,934−$32,694−$1,789−$93,252
Capital spending−$5−$90,893−$4−$4———
Free cash flow−$396,000−$1.1m−$371,868−$40,938−$32,694−$1,789−$93,252

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$1.5m$1.0m$632,057$6,163$5,470$4,542$20,870$9,849
Gross profit$935,916$550,489$448,763$4,323$3,832$3,182$9,070$8,864
Operating income$218,377−$6,902−$8.9m−$628,808−$563,333−$415,408−$689,112−$259,173
Net income$200,358−$25,377−$9.0m−$649,775−$605,563−$456,855−$718,789−$271,333
Diluted earnings per share0.01-0.00-0.32-0.02-0.02-0.02-0.03-0.01
Total assets$814,726$516,600$390,043$9.3m$9.4m$9.8m$10.0m$19.3m
Cash and short-term investments$178,872$87,818—$38,854$4,678$129,331—$16,202
Debt$794,787$5,986—$23,620$32,257$34,791—$901,284
Shareholders' equity−$1.1m−$1.2m−$1.2m$7.8m$8.4m$9.8m$8.6m$18.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue165.8%——
Operating income287.4%467.7%80.3%
Net income289.5%—80.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin69.4%71.9%——
Operating margin-1675.9%-1588.9%——
Net margin-1703.2%-1613.4%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings-0.0———
Price to sales0.20.00.00.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return650%22%710%14%363%2786%1405%1148103%6280748%170567%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 1 Nov 2024
  • 2000-to-1 reverse split · 2 Sept 2022
  • 30-for-1 split · 10 Jun 2010

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.